These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8751632)

  • 21. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives.
    Natale M; Mirone G; Rotondo M; Moraci A
    Clin Neurol Neurosurg; 2012 May; 114(4):321-5. PubMed ID: 22104692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
    Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
    Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study.
    Herman RM; D'Luzansky SC; Ippolito R
    Clin J Pain; 1992 Dec; 8(4):338-45. PubMed ID: 1493344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intrathecal baclofen for severe spasticity].
    Ueta T
    Brain Nerve; 2008 Dec; 60(12):1415-20. PubMed ID: 19110752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
    Albright AL; Gilmartin R; Swift D; Krach LE; Ivanhoe CB; McLaughlin JF
    J Neurosurg; 2003 Feb; 98(2):291-5. PubMed ID: 12593613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.
    Borrini L; Bensmail D; Thiebaut JB; Hugeron C; Rech C; Jourdan C
    Arch Phys Med Rehabil; 2014 Jun; 95(6):1032-8. PubMed ID: 24407102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal baclofen for spastic hypertonia from stroke.
    Meythaler JM; Guin-Renfroe S; Brunner RC; Hadley MN
    Stroke; 2001 Sep; 32(9):2099-109. PubMed ID: 11546903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time course of the effect of a bolus dose of intrathecal baclofen on severe cerebral spasticity.
    Pohl M; Rockstroh G; Rückriem S; Mehrholz J; Pause M; Koch R; Strik H
    J Neurol; 2003 Oct; 250(10):1195-200. PubMed ID: 14586601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intrathecal baclofen in treatment of spasticity casuistry of the Centro Hospitalar de Coimbra].
    Veiros I; Martins L; Martins F
    Acta Med Port; 2006; 19(3):217-24. PubMed ID: 17234083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional outcome of intrathecal baclofen administration for severe spasticity.
    Boviatsis EJ; Kouyialis AT; Korfias S; Sakas DE
    Clin Neurol Neurosurg; 2005 Jun; 107(4):289-95. PubMed ID: 15885386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of the effect of a bolus dose of intrathecal baclofen by continuous measurement of force under fibreglass casts.
    Pohl M; Rockstroh G; Rückriem S; Mehrholz J; Mrass G; Pause M
    J Neurol; 2002 Sep; 249(9):1254-62. PubMed ID: 12242550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia.
    Margetis K; Korfias S; Boutos N; Gatzonis S; Themistocleous M; Siatouni A; Dalivigka Z; Flaskas T; Stranjalis G; Boviatsis E; Sakas D
    Clin Neurol Neurosurg; 2014 Aug; 123():142-5. PubMed ID: 24973568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal and Oral Baclofen Use in Adults With Spinal Cord Injury: A Systematic Review of Efficacy in Spasticity Reduction, Functional Changes, Dosing, and Adverse Events.
    Dietz N; Wagers S; Harkema SJ; D'Amico JM
    Arch Phys Med Rehabil; 2023 Jan; 104(1):119-131. PubMed ID: 35750207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity.
    Saltuari L; Kronenberg M; Marosi MJ; Kofler M; Russegger L; Rifici C; Bramanti P; Gerstenbrand F
    Acta Neurol (Napoli); 1992 Jun; 14(3):187-94. PubMed ID: 1442217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen.
    Dressnandt J; Conrad B
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):168-73. PubMed ID: 8708647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study.
    Ochs G; Struppler A; Meyerson BA; Linderoth B; Gybels J; Gardner BP; Teddy P; Jamous A; Weinmann P
    J Neurol Neurosurg Psychiatry; 1989 Aug; 52(8):933-9. PubMed ID: 2487035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intrathecal baclofen in severe spasticity due to multiple sclerosis].
    Sławek J; Zieliński P; Hołub-Kucharska W; Kaniszewska J; Paczkowska M; Słoniewski P
    Neurol Neurochir Pol; 2003; 37(5):1135-42; discussion 1143. PubMed ID: 15174259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term intrathecal baclofen therapy in patients with intractable spasticity.
    Becker WJ; Harris CJ; Long ML; Ablett DP; Klein GM; DeForge DA
    Can J Neurol Sci; 1995 Aug; 22(3):208-17. PubMed ID: 8529173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal baclofen application in patients with supraspinal spasticity secondary to severe traumatic brain injury.
    Rifici C; Kofler M; Kronenberg M; Kofler A; Bramanti P; Saltuari L
    Funct Neurol; 1994; 9(1):29-34. PubMed ID: 8082851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of intrathecal baclofen (ITB) therapy in spacticity.
    Ucar T; Kazan S; Turgut U; Samanci NK
    Turk Neurosurg; 2011 Jan; 21(1):59-65. PubMed ID: 21294093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.